Good morning. I’ve decided to paint the walls in one of my rooms a dark brown. I may deeply regret this decision. Please send any painting tips!

The need-to-know this morning

Lilly will review applications for special access to experimental drug

Over a month ago, STAT reported that Eli Lilly had granted a single 79-year-old patient special access to its next-gen obesity drug retatrutide. Now, the pharma company says it will allow other patients to apply for early access to the therapy as well.